Long-Term Effectiveness of Natalizumab in Patients with Relapsing-Remitting Multiple Sclerosis Treated in the Routine Care in Greece: Results from the Multicenter, Observational 5-Year Prospective Study ‘TOPICS Greece’-Reference-Cited by-同舟云学术

Long-Term Effectiveness of Natalizumab in Patients with Relapsing-Remitting Multiple Sclerosis Treated in the Routine Care in Greece: Results from the Multicenter, Observational 5-Year Prospective Study ‘TOPICS Greece’

Published:2021-08-24 Issue:10 Volume:41 Page:865-874
ISSN:1173-2563
Container-title:Clinical Drug Investigation
language:en
Short-container-title:Clin Drug Investig

Author:

Efthimios Dardiotis,Georgios Karachalios,Antonia Alexopoulou,Rania Gourgioti^ORCID,Maria-Eleutheria Evangelopoulos,

Funder

Genesis Pharma

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s40261-021-01073-y.pdf

Reference30 articles.

1. Compston A, Coles A. Multiple sclerosis. Lancet. 2008;372(9648):1502–17. https://doi.org/10.1016/S0140-6736(08)61620-7.

2. Reich DS, Lucchinetti CF, Calabresi PA. Multiple sclerosis. N Engl J Med. 2018;378(2):169–80. https://doi.org/10.1056/NEJMra1401483.

3. Lopes Pinheiro MA, Kooij G, Mizee MR, Kamermans A, Enzmann G, Lyck R, Schwaninger M, Engelhardt B, de Vries HE. Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke. Biochim Biophys Acta. 2016;1862(3):461–71. https://doi.org/10.1016/j.bbadis.2015.10.018.

4. Yednock TA, Cannon C, Fritz LC, Sanchez-Madrid F, Steinman L, Karin N. Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha4beta1 integrin. Nature. 1992;356(6364):63–6. https://doi.org/10.1038/356063a0.

5. Baron JL, Madri JA, Ruddle NH, Hashim G, Janeway CA Jr. Surface expression of α4 integrin by CD4 T cells is required for their entry into brain parenchyma. J Exp Med. 1993;177(1):57–68. https://doi.org/10.1084/jem.177.1.57.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. q‐Space Myelin Map: A new myelin‐specific imaging technique for treatment monitoring of multiple sclerosis;Clinical and Experimental Neuroimmunology;2024-06-02

2. q-Space Myelin Map: A new myelin-specific imaging technique for treatment monitoring of multiple sclerosis;2023-10-03

3. Real-world treatment outcomes and safety of natalizumab in Finnish multiple sclerosis patients;Multiple Sclerosis Journal - Experimental, Translational and Clinical;2023-10

4. Use of Structured Template and Reporting Tool for Real-World Evidence for Critical Appraisal of the Quality of Reporting of Real-World Evidence Studies: A Systematic Review;Value in Health;2023-03

5. Use of natalizumab in persons with multiple sclerosis: 2022 update;Multiple Sclerosis and Related Disorders;2022-09